Fulltext

Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter

Cachat, Francois ; Bardy, Daniel ; Durussel, Claudine ; Di Paolo, Ermindo

In: Pediatric Nephrology, 2006, vol. 21, no. 2, p. 301-302

Ajouter à la liste personnelle
    Titre
    • Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter
    Auteur
    • Cachat, Francois. Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Rue du Bugnon, 1011, Lausanne, Vaud, Switzerland
    • Bardy, Daniel. Central Chemical Laboratory, University Hospital, Lausanne, Switzerland
    • Durussel, Claudine. Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Rue du Bugnon, 1011, Lausanne, Vaud, Switzerland
    • Di Paolo, Ermindo. Department of Pharmacy, University Hospital, Lausanne, Switzerland
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:311023
    Summary
    Alteplase has been shown to be effective in preventing central venous access clotting in patients on hemodialysis. Because of a high phosphorus content in its excipient, it can inadvertently contaminate blood samples, leading the physician in care of the patient to erroneously increase dialysis time or change diet in order to control the pseudo-hyperphosphatemia